Skip to main content
. 2021 Oct 30;10(21):5116. doi: 10.3390/jcm10215116

Table 3.

Distribution of socio-demographic, clinical, and care-related characteristics according to dead/alive status at 1 year mortality. Incident hemodialysis patients from RRDTL Lazio Region (Italy) 2008–2017.

1 YEAR DEATH
Dead Alive Total p-Value *
n %col %row n %col %row n
Total 1354 100 16.5 6861 100 83.5 8215
Gender 0.2205
Males 855 63.2 16.1 4452 64.9 83.9 5307
Females 499 36.9 17.2 2409 35.1 82.8 2908
Age (years) mean ± std 1354 74.8 ± 10.9 6861 67.0 ± 14.5 8215
Age class (years) <0.001
19–49 45 3.3 4.6 939 13.7 95.4 984
50–64 172 12.7 9.8 1576 23 90.2 1748
65–74 327 24.2 15.1 1835 26.8 84.9 2162
75–84 583 43.1 22.4 2019 29.4 77.6 2602
85+ 227 16.8 31.6 492 7.2 68.4 719
Education qualification <0.001
No qualifications/Elementary School/Middle School 992 73.3 18.2 4446 64.8 81.8 5438
High School/Degree and more 362 26.7 13 2415 35.2 87 2777
Body Mass Index <0.001
Underweight (BMI < 18.0) 118 8.7 26.8 323 4.7 73.2 441
Normal weight (18.0 ≤ BMI < 25.0) 743 54.9 17.7 3449 50.3 82.3 4192
Overweight (25.0 ≤ BMI < 30.0) 357 26.4 14.7 2079 30.3 85.3 2436
Obese (BMI ≥ 30.0) 136 10 11.9 1010 14.7 88.1 1146
Self-sufficient <0.001
Complete 247 18.2 6.6 3510 51.2 93.4 3757
Little self-sufficient 397 29.3 16.2 2049 29.9 83.8 2446
Not self-sufficient 710 52.4 35.3 1302 19 64.7 2012
Cause of ESRD <0.001
Unknown 388 28.7 18.9 1668 24.3 81.1 2056
Diabetic nephropathy 318 23.5 17.1 1542 22.5 82.9 1860
Renal vascular disease 320 23.6 16.4 1629 23.7 83.6 1949
Glomerulonephritis 45 3.3 7 602 8.8 93 647
Interstitial nephritis, toxic/pyelonephritis 94 6.9 20.1 374 5.5 79.9 468
Other nephropathies 74 5.5 20.7 284 4.1 79.3 358
Systemic disease 83 6.1 28.5 208 3 71.5 291
Cystic renal disease/familial nephropathy 28 2.1 5.1 523 7.6 94.9 551
Renal malformation 4 0.3 11.4 31 0.5 88.6 35
Comorbidities
Heart disease 683 50.4 22.7 2326 33.9 77.3 3009 <0.001
Peripheral vascular diseases 242 17.9 25.9 692 10.1 74.1 934 <0.001
Cerebrovascular disease 157 11.6 24.7 478 7 75.3 635 <0.001
Chronic obstructive pulmonary disease 289 21.3 24.7 882 12.9 75.3 1171 <0.001
Cancer 274 20.2 28.1 702 10.2 71.9 976 <0.001
Lipid metabolism’s alteration 71 5.2 12.8 484 7.1 87.2 555 0.0153
Neurological disease 79 5.8 30 184 2.7 70 263 <0.001
Cardiovascular Risk Factors (Hypertension, Obesity, Diabetes) 944 69.7 14.9 5414 78.9 85.2 6358 <0.001
Vascular access <0.001
FAV 1043 77 25.1 3115 45.4 74.9 4158
CVC 311 23 7.7 3746 54.6 92.3 4057
Type of dialysis unit 0.2191
Public hospital 524 38.7 17.1 2534 36.9 82.9 3058
Private clinic 830 61.3 16.1 4327 63.1 83.9 5157
Pre-dialysis counselling 0.0003
Yes 975 72 15.7 5257 76.6 84.4 6232
No 379 28 19.1 1604 23.4 80.9 1983
Laboratory findings, mean ± std n mean ± std n mean ± std Total p-value
Serum creatinine (mg/dL) 1349 6.0 ± 2.1 6845 6.9 ± 2.3 8194 <0.001
Hb (g/dL) 1352 9.9 ± 1.3 6859 10.3 ± 1.4 8211 <0.001
CPK (U/L) 1354 8.6 ± 0.8 6861 8.7 ± 0.8 8215 <0.001
Serum phosphate level (mg/dL) 1338 4.7 ± 1.4 6809 5.0 ± 1.4 8147 <0.001
Serum albumin (g/L) 1344 3.4 ± 0.5 6833 3.6 ± 0.5 8177 <0.001

* Chi-square test or Fisher’s exact for categorical variables. T-test or Wilcoxon rank sum test for continuous variables. BMI, body mass index; ESRD, end-stage renal disease; AVF, arteriovenous fistula; CVC, central venous catheter; Hb, hemoglobin; CPK, creatine phosphokinase.